KDC is a specialist in decommissioning and demolition in the pharmaceutical market with a successful track record of delivering decommissioning and demolition projects for organisations including Astra Zeneca, MSD, GSK, Sanofi Aventis and Solvay.
KDC offers a proven team with the technical and managerial capabilities aligned to the varying scopes of work that we may encounter through the course of a plant decommissioning programme.
From initial surveys, hazard abatement, de-planting and demolition to waste characterisation, separation and disposal, we have an impeccable safety record in this most demanding and challenging of environments.
Pharmaceutical customers choose KDC because of our track record, our price competitiveness, the calibre of our workforce and financial stability.
We are practised in working within the constraints of a live process production arena. This has aided the development of the skills necessary to reduce the impact of our operations on adjacent operating facilities. Our specialist skills and advanced equipment ensures safe decommissioning and demolition incorporating best practice and value engineering techniques with minimal environmental impact.
Suitably qualified and experienced personnel and comprehensive Safe Systems of Work confirm that KDC is the preferred partner in this challenging sector.